At Aesthetics 360, were proud to showcase the remarkable transformations our clients have achieved with Semaglutide and L-Carnitine injections: Real-Life Transformations at Aesthetics 360 Discover firsthand accounts of individuals who have harnessed the power of these injections to achieve their weight loss goals
Mention Genetic Personalization and Precision Testing The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
A 26-week, multicenter, double-blind trial assessed the efficacy and safety of once-daily semaglutide compared to once-daily liraglutide and placebo in patients with type 2 diabetes
diabetesjournals.org Ishiguro M, et al
Research Linking Ozempic to Blindness Research continues to emerge regarding serious side effects of Ozempic and other GLP-1 receptor agonists: January 2026: Patients Who Experienced Vision Loss After Ozempic Can Make Their Case in Federal Court In December of 2025, the Joint Panel on Multidistrict Litigation chose to centralize lawsuits filed by people who took GLP-1 drugs and then were diagnosed with NAION
